Company page

Immunovia Ab

Immunovia Ab is a public company traded on the Swedish market under the ticker IMMNOV. The company has a market capitalization of approximately 12.6 million USD. Immunovia focuses on developing innovative diagnostic solutions for cancer detection and management.

profileIMMNOV:OMXSTOAI content: aiUpdated June 24, 2026/company/immunovia-ab/c-vsmzddsw
Immunovia Ab logo
Ticker
IMMNOV:OMXSTO
Asset type
Stock
Market cap
$12.6M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
OMXSTO
Currency
SEK